Cargando…
Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
Tuberculosis (TB) is one of the deadliest diseases, causing ∼2 million deaths annually worldwide. Mycobacterium bovis bacillus Calmette-Guérin (BCG), the only TB vaccine in common use, is effective against disseminated and meningeal TB in young children but is not effective against adult pulmonary T...
Autores principales: | Ahmad, Shaheer, Bhattacharya, Debapriya, Kar, Santosh, Ranganathan, Anand, Van Kaer, Luc, Das, Gobardhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803339/ https://www.ncbi.nlm.nih.gov/pubmed/31481412 http://dx.doi.org/10.1128/IAI.00291-19 |
Ejemplares similares
-
Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015) -
Commensal Microbes Affect Host Humoral Immunity to Bordetella pertussis Infection
por: Zhang, Youyi, et al.
Publicado: (2019) -
Systematic Evaluation of Mycobacterium tuberculosis Proteins for Antigenic Properties Identifies Rv1485 and Rv1705c as Potential Protective Subunit Vaccine Candidates
por: Wang, Yaguo, et al.
Publicado: (2021) -
Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host
por: Alhassan, Andy, et al.
Publicado: (2019) -
Vaccination with a ZNF2(oe) Strain of Cryptococcus Provides Long-Lasting Protection against Cryptococcosis and Is Effective in Immunocompromised Hosts
por: Pham, Tuyetnhu, et al.
Publicado: (2023)